D. Lee and M. Weinblatt, Rheumatoid arthritis, The Lancet, vol.358, issue.9285, pp.903-914, 2001.
DOI : 10.1016/S0140-6736(01)06075-5

A. Crisp, C. Chapman, S. Kirkham, A. Schiller, and S. Krane, Articular mastocytosis in rheumatoid arthritis, Arthritis & Rheumatism, vol.130, issue.8, pp.845-51, 1984.
DOI : 10.1002/art.1780270802

H. Godfrey, C. Ilardi, W. Engber, and F. Graziano, Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases, Arthritis & Rheumatism, vol.69, issue.8, pp.852-858, 1984.
DOI : 10.1002/art.1780270803

P. Nigrovic and D. Lee, Synovial mast cells: role in acute and chronic arthritis, Immunological Reviews, vol.104, issue.1, pp.19-37, 2007.
DOI : 10.1186/ar1446

M. Van-den-broek, W. Van-den-berg, and L. Van-de-putte, The role of mast cells in antigen induced arthritis in mice, J Rheumatol, vol.15, issue.4, pp.544-51, 1988.

M. Corr and B. Crain, The Role of Fc?R Signaling in the K/B x N Serum Transfer Model of Arthritis, The Journal of Immunology, vol.169, issue.11, pp.6604-6613, 2002.
DOI : 10.4049/jimmunol.169.11.6604

D. Lee, D. Friend, M. Gurish, C. Benoist, D. Mathis et al., Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis, Science, vol.297, issue.5587, pp.1689-92, 2002.
DOI : 10.1126/science.1073176

N. Schubert, J. Dudeck, P. Liu, A. Karutz, S. Speier et al., Mast Cell Promotion of T Cell-Driven Antigen-Induced Arthritis Despite Being Dispensable for Antibody-Induced Arthritis in Which T Cells Are Bypassed, Arthritis & Rheumatology, vol.37, issue.4, pp.903-916, 2015.
DOI : 10.1002/art.38996

D. Van-der-velden, H. Lagraauw, A. Wezel, P. Launay, J. Kuiper et al., Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile, Arthritis Research & Therapy, vol.13, issue.Suppl 3, p.138, 2016.
DOI : 10.1016/j.ejphar.2015.03.085

R. Stevens and R. Adachi, Protease?proteoglycan complexes of mouse and human mast cells and importance of their ?-tryptase?heparin complexes in inflammation and innate immunity, Immunological Reviews, vol.32, issue.1, pp.155-67, 2007.
DOI : 10.1006/jmbi.1997.1582

G. Pejler, E. Ronnberg, I. Waern, and S. Wernersson, Mast cell proteases: multifaceted regulators of inflammatory disease, Blood, vol.115, issue.24, pp.4981-90, 2010.
DOI : 10.1182/blood-2010-01-257287

H. Mcneil, K. Shin, I. Campbell, I. Wicks, R. Adachi et al., The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis, Arthritis & Rheumatism, vol.185, issue.8, pp.2338-2384, 2008.
DOI : 10.1002/art.23639

K. Shin, P. Nigrovic, J. Crish, E. Boilard, H. Mcneil et al., Mast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes, The Journal of Immunology, vol.182, issue.1, pp.647-56, 2009.
DOI : 10.4049/jimmunol.182.1.647

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610352/pdf

P. Pereira, A. Bergner, S. Macedo-ribeiro, R. Huber, G. Matschiner et al., Human beta-tryptase is a ring-like tetramer with active sites facing a central pore, Nature, vol.392, issue.6673, pp.306-317, 1998.

G. Caughey, Mast cell tryptases and chymases in inflammation and host defense, Immunological Reviews, vol.168, issue.1, pp.141-54, 2007.
DOI : 10.1067/mai.2001.114989

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275918

J. Cairns, Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders, Pulmonary Pharmacology & Therapeutics, vol.18, issue.1, pp.55-66, 2005.
DOI : 10.1016/j.pupt.2004.09.032

Y. Radhakrishnan, K. Hamil, J. Tan, G. Grossman, P. Petrusz et al., Novel Partners of SPAG11B Isoform D in the Human Male Reproductive Tract1, Biology of Reproduction, vol.81, issue.4, pp.647-56, 2009.
DOI : 10.1095/biolreprod.109.077545

M. Selsted, S. Harwig, T. Ganz, J. Schilling, and R. Lehrer, Primary structures of three human neutrophil defensins., Journal of Clinical Investigation, vol.76, issue.4, pp.1436-1445, 1985.
DOI : 10.1172/JCI112121

K. Taylor, D. Clarke, B. Mccullough, W. Chin, E. Seo et al., Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of ?-Defensin 3, Journal of Biological Chemistry, vol.283, issue.11, pp.6631-6640, 2008.
DOI : 10.1074/jbc.M709238200

A. Patil, Y. Cai, Y. Sang, F. Blecha, and G. Zhang, Cross-species analysis of the mammalian ??-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract, Physiological Genomics, vol.23, issue.1, pp.5-17, 2005.
DOI : 10.1152/physiolgenomics.00104.2005

S. Hall, S. Yenugu, Y. Radhakrishnan, M. Avellar, P. Petrusz et al., Characterization and functions of beta defensins in the epididymis, Asian Journal of Andrology, vol.9, issue.4, pp.453-62, 2007.
DOI : 10.1111/j.1745-7262.2007.00298.x

C. Ribeiro, D. Queiroz, M. Patrao, A. Denadai-souza, R. Romano et al., Dynamic changes in the spatio-temporal expression of the ?-defensin SPAG11C in the developing rat epididymis and its regulation by androgens, Molecular and Cellular Endocrinology, vol.404, pp.141-50, 2015.
DOI : 10.1016/j.mce.2015.01.013

M. Krishna, A. Chauhan, L. Little, K. Sampson, R. Hawksworth et al., Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma, Journal of Allergy and Clinical Immunology, vol.107, issue.6, pp.1039-1084, 2001.
DOI : 10.1067/mai.2001.115631

N. Staite, K. Richard, D. Aspar, K. Franz, L. Galinet et al., Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin, Arthritis & Rheumatism, vol.151, issue.2, pp.253-60, 1990.
DOI : 10.1002/art.1780330215

K. Lawlor, I. Campbell, O. Donnell, K. Wu, L. Wicks et al., Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis, Arthritis & Rheumatism, vol.105, issue.2, pp.442-50, 2001.
DOI : 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???CT Method, Methods, vol.25, issue.4, pp.402-410, 2001.
DOI : 10.1006/meth.2001.1262

A. Denadai-souza, C. Lde, L. Ribela, M. Keeble, J. Costa et al., Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint, European Journal of Pain, vol.104, issue.8, pp.812-821, 2009.
DOI : 10.1016/j.ejpain.2008.09.012

E. Gouze, R. Pawliuk, C. Pilapil, J. Gouze, C. Fleet et al., In Vivo Gene Delivery to Synovium by Lentiviral Vectors, Molecular Therapy, vol.5, issue.4, pp.397-404, 2002.
DOI : 10.1006/mthe.2002.0562

J. Geurts, E. Vermeij, D. Pohlers, O. Arntz, R. Kinne et al., A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts, Annals of the Rheumatic Diseases, vol.70, issue.7, pp.1311-1320, 2011.
DOI : 10.1136/ard.2010.135665

M. Steinhoff, N. Vergnolle, S. Young, M. Tognetto, S. Amadesi et al., Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism, Nat Med, vol.6, issue.2, pp.151-159, 2000.

H. Palmer, E. Kelso, J. Lockhart, C. Sommerhoff, R. Plevin et al., Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells, Arthritis & Rheumatism, vol.127, issue.11, pp.3532-3572, 2007.
DOI : 10.1002/art.22936

R. Lohman, A. Cotterell, G. Barry, L. Liu, J. Suen et al., An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats, The FASEB Journal, vol.26, issue.7, pp.2877-87, 2012.
DOI : 10.1096/fj.11-201004

A. Denadai-souza, N. Cenac, C. Casatti, P. Camara, L. Yshii et al., PAR2 and Temporomandibular Joint Inflammation in the Rat, Journal of Dental Research, vol.89, issue.10, pp.1123-1131, 2010.
DOI : 10.1177/0022034510375284

A. Denadai-souza, L. Martin, M. De-paula, M. De-avellar, M. Muscara et al., Role of transient receptor potential vanilloid 4 in rat joint inflammation, Arthritis & Rheumatism, vol.134, issue.6, pp.1848-58, 2012.
DOI : 10.1002/art.34345

F. Russell, N. Schuelert, V. Veldhoen, M. Hollenberg, and J. Mcdougall, receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint, British Journal of Pharmacology, vol.27, issue.Suppl. 1, pp.1665-78, 2012.
DOI : 10.1111/j.1476-5381.2012.02120.x

E. Borbely, K. Sandor, A. Markovics, A. Kemeny, E. Pinter et al., Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees, Inflammation Research, vol.44, issue.Suppl 3, pp.725-761, 2016.
DOI : 10.1016/j.npep.2010.02.003

J. Zhou, W. Xing, D. Friend, K. Austen, and H. Katz, mice does not impair antibody-mediated arthritis, The Journal of Experimental Medicine, vol.148, issue.12, pp.2797-802, 2007.
DOI : 10.1074/jbc.M203163200

M. Kaplan, Role of neutrophils in systemic autoimmune diseases, Arthritis Research & Therapy, vol.15, issue.5, p.219, 2013.
DOI : 10.1186/ar4325

S. Nakano, T. Mishiro, S. Takahara, H. Yokoi, D. Hamada et al., Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis, Clinical Rheumatology, vol.52, issue.6, pp.1284-92, 2007.
DOI : 10.1007/s10067-006-0495-8

T. Hirano, T. Matsuda, M. Turner, N. Miyasaka, G. Buchan et al., Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis, European Journal of Immunology, vol.73, issue.11, pp.1797-801, 1988.
DOI : 10.1002/eji.1830181122

L. Calabrese, R. , and S. , IL-6 biology: implications for clinical targeting in rheumatic disease, Nature Reviews Rheumatology, vol.65, issue.12, pp.720-727, 2014.
DOI : 10.1371/journal.pone.0014328

M. Fujimoto, S. Serada, M. Mihara, Y. Uchiyama, H. Yoshida et al., Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses, Arthritis & Rheumatism, vol.80, issue.12, pp.3710-3719, 2008.
DOI : 10.1002/art.24126

M. Murakami and N. Nishimoto, The value of blocking IL-6 outside of rheumatoid arthritis: current perspective, Current Opinion in Rheumatology, vol.23, issue.3, pp.273-280, 2011.
DOI : 10.1097/BOR.0b013e3283456797

K. Lawlor, P. Wong, I. Campbell, N. Van-rooijen, and I. Wicks, Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor, Arthritis & Rheumatism, vol.100, issue.12, pp.3749-54, 2005.
DOI : 10.1002/art.21495